PrEP

9 drugs in development·8 companies·3 clinical trials

Drug Pipeline by Phase

Approved(7)

Drug	Company
aprepitant	Mylan II B.V. (MYL)
hydrocortisone	Aptinyx Inc. (APTX)
methylprednisolone	Amneal Pharmaceuticals, Inc. (AMRX)
metyrosine	Amneal Pharmaceuticals, Inc. (AMRX)
sodium	GT Biopharma, Inc. (GTBP)
sodium	TESARO, Inc. (TSRO)
sterile water	NEXUS BIOPHARMA INC (NEXS)

Preclinical(1)

Drug	Company
Antibody drug conjugate (ADC) candidates	Fulgent Genetics Inc. (FLGT)

Unknown(1)

Drug	Company
Alinity® m and m2000™	ABBOTT LABORATORIES (ABT)

BioSniper tracks 9 drugs in development for PrEP across 8 companies.

There are 3 clinical trials targeting PrEP tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.